Form 6-K ASTRAZENECA PLC For: Sep 26
http://archive.fast-edgar.com/20140926/AD22A22CZ22WQ2Z222282MDZNDJAPZO2D262
Filed on: September 26, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
- ConTemporary Locums Ushers in a New Era: Introducing Era Locums
- G-P Named EOR Leader in G2's 2024 Spring Report
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!